A Randomized Controlled Trial on the Usefulness of Gait Rehabilitation after Cervical Myelopathy Surgery

A Randomized Controlled Trial of the Usefulness of Gait Rehabilitation in the Acute Postoperative Period of Compressive Cervical Myelopathy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs032250083

Enrollment

Registered

2025-05-02

Start date

2025-05-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients determined to require postoperative rehabilitation

Interventions

Gait training using a recumbent ergometer, treadmill walking, and unloaded walker

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who have been fully informed of the study and who, with full understanding, have given written consent of their own free will to participate in the study 2)Patients undergoing surgery with a diagnosis of cervical myelopathy, ossification of the posterior longitudinal ligament, herniated disc, or extramedullary spinal cord tumor 3)Patients with a score of 1 or 2 on the Japanese Orthopedic Association-Leg Motor Function (JOA-LE) of the Japanese Orthopedic Association Cervical Myelopathy Treatment Outcome Criteria 4)Eligible ages range from 50 to 90 years old 5)Gender is irrelevant. 6)Patients who are able to undergo in-patient follow-up for 6 months after surgery

Exclusion criteria

Exclusion criteria: 1) Patients scheduled for anterior decompression and fixation 2) History of myelopathy surgery 3) Patients with impaired consciousness 4) Patients with concomitant neurological diseases that may affect the evaluation of neurological symptoms, such as cerebral infarction 5) Patients with preoperative and postoperative lower extremity muscle strength scores totaling 42 or less on both sides or MMT 3 or less in one of the key muscles, consisting of muscles representing the 5 myelinated segments L2-S1 of the ASIA assessment criteria 6) Other patients judged unsuitable for the study by the investigator(s).

Design outcomes

Primary

Measure	Time frame
Change in 10 m maximum walking speed (m/sec) before and 14 days after surgery	—

Secondary

Measure	Time frame
1)10m maximum walking speed (m/sec) (crude point and amount of change) 2) Percentage of 0.1 m/sec improvement in 10 m maximum walking speed (m/sec) change 3) Amount of change in 10m maximum walking speed (m/sec) by number of rehabilitation sessions 4)10m maximum walking speed (steps) (crude score and amount of change) 5)Change in 10m maximum walking speed (m/sec) relative to change in JOA score 6)Timed up and Go test (sec) (crude point and amount of change) 7)JOA-LE (crude point and amount of change) 8)2-minute walk (crude point and amount of change)	—

Measure

Time frame

1)10m maximum walking speed (m/sec) (crude point and amount of change) 2) Percentage of 0.1 m/sec improvement in 10 m maximum walking speed (m/sec) change 3) Amount of change in 10m maximum walking speed (m/sec) by number of rehabilitation sessions 4)10m maximum walking speed (steps) (crude score and amount of change) 5)Change in 10m maximum walking speed (m/sec) relative to change in JOA score 6)Timed up and Go test (sec) (crude point and amount of change) 7)JOA-LE (crude point and amount of change) 8)2-minute walk (crude point and amount of change)

—

Contacts

Public ContactRyo Fukata

Chiba University Hospital

alice_cute_0312@chiba-u.jp+81-43-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026